Mazor lands Korean approval for Renaissance spinal surgery robot
Mazor Robotics’ (PINK:MZRTF) Korean distributor BR Holdings won government approval to market the Renaissance surgical guidance system and is currently pursuing reimbursement.
Korea represents the 2nd largest per capita spinal surgery market in the world, with 18% annual growth rate since 2003 and an existing interest in surgical robotics.
"The Korean healthcare system currently supports 36 da Vinci surgical robots," CEO Ori Hadomi said in prepared remarks. "We expect Korea to be a very strong market for our surgical robots and serve as a gateway to the Asia Pacific region, as it has in the past for other robotic technologies."
Mazor plans to immediately mount a commercial launch for the devices "to establish early adopters and build local clinical experience."
The company earlier this month also touted the 1st cases using its robotic platform in guided brain operations.
Read more
Kinetics Concepts wins FDA OK for surgical closure with V.A.C. system
Kinetic Concepts touted expanded FDA clearance for its V.A.C. therapy system for management of closed surgical incisions. The new indication allows surgeons to use the device to treat longer incisions.
Read more
Siemens touts FDA win for Somatom Perspective CT scanner
Siemens (NYSE:SI) won FDA 510(k) clearance for its Somatom Perspective system, a 128-slice computed tomography scanner designed to improve efficiency, cut radiation dose and reduce costs.
Read more
- OSI wins 510(k) clearance for the AriaTele telemetry transmitter
- Insightra receives CE Mark for new suite of ventral hernia repair kits
- Cardiosolutions announces FDA win for Dexterity steerable heart access introducer
- KFx lands FDA OK for smaller AppianFx tissue fixation anchor
